Leishmaniasis has been reported by U.S. troops stationed in Iraq, including visceral leishmaniasis. Endemic diseases include dengue fever, filariasis, leishmaniasis, malaria, meningitis, schistosomiasis, and sleeping sickness. Cutaneous leishmaniasis is the most common form of leishmaniasis affecting humans. Miltefosine, an oral medication, is effective against both visceral and cutaneous leishmaniasis. A number of topical treatments may be used for cutaneous leishmaniasis. Most species of "Leishmania" are capable of infecting humans and causing cutaneous leishmaniasis. The evidence around the treatment of cutaneous leishmaniasis is poor. Kinetoplastid infections include African sleeping sickness, Chagas' disease, and Leishmaniasis. It is an option for both visceral leishmaniasis and cutaneous leishmaniasis. The best treatment for American cutaneous and mucocutaneous leishmaniasis (ACML) is not known. In 2009, 3,314 tonnes were produced for malaria control and visceral leishmaniasis. Leishmania is a genus of trypanosomes that are responsible for the disease leishmaniasis. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. Serological testing is much more frequently used in areas where leishmaniasis is endemic. Dr. Jebejian had published many valuable researches about leishmaniasis and trachoma.